Author's posts
AHIP: Rebates not driving rise in drug pricing
A recent analysis prepared on behalf of America’s Health Insurance Plans (AHIP) indicates that drug rebates have not been the primary driver of rising drug prices—as some advocates have claimed.
Doctors, executives see little progress on value-based care
Value-based healthcare may be the hot topic right now, but all that attention has yet to make much of a mark on the industry. That’s the perspective of physicians and health plan executives who said that despite advances in technology, there’s still a …
